These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19827134)

  • 1. Didanosine polymorphism in a supercritical antisolvent process.
    Bettini R; Menabeni R; Tozzi R; Pranzo MB; Pasquali I; Chierotti MR; Gobetto R; Pellegrino L
    J Pharm Sci; 2010 Apr; 99(4):1855-70. PubMed ID: 19827134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study and characterization of crystalline hydrate/polymorph forms of 5,11-dihydro-11-ethyl-5-methyl-8-(2-(1-oxido-4-quinolinyl)ethyl-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepin-6-one by solid-state NMR and solution NMR.
    Gonnella NC; Smoliga JA; Campbell S; Busacca CA; Cerreta M; Varsolona R; Norwood DL
    J Pharm Biomed Anal; 2010 Apr; 51(5):1047-53. PubMed ID: 20018474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal doping aided by rapid expansion of supercritical solutions.
    Vemavarapu C; Mollan MJ; Needham TE
    AAPS PharmSciTech; 2002; 3(4):E29. PubMed ID: 12916923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro dissolution enhancement of micronized l-nimodipine by antisolvent re-crystallization from its crystal form H.
    Zu Y; Li N; Zhao X; Li Y; Ge Y; Wang W; Wang K; Liu Y
    Int J Pharm; 2014 Apr; 464(1-2):1-9. PubMed ID: 24456674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process.
    Kim MS; Jin SJ; Kim JS; Park HJ; Song HS; Neubert RH; Hwang SJ
    Eur J Pharm Biopharm; 2008 Jun; 69(2):454-65. PubMed ID: 18359211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recrystallization of fluconazole using the supercritical antisolvent (SAS) process.
    Park HJ; Kim MS; Lee S; Kim JS; Woo JS; Park JS; Hwang SJ
    Int J Pharm; 2007 Jan; 328(2):152-60. PubMed ID: 16959448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of supercritical fluids to enhance the dissolution behaviors of Furosemide by generation of microparticles and solid dispersions.
    De Zordi N; Moneghini M; Kikic I; Grassi M; Del Rio Castillo AE; Solinas D; Bolger MB
    Eur J Pharm Biopharm; 2012 May; 81(1):131-41. PubMed ID: 22266263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of phenytoin nanoparticles using rapid expansion of supercritical solution with solid cosolvent (RESS-SC) process.
    Thakur R; Gupta RB
    Int J Pharm; 2006 Feb; 308(1-2):190-9. PubMed ID: 16352406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Particle preparation of pharmaceutical compounds using supercritical antisolvent process: current status and future perspectives.
    Kumar R; Thakur AK; Kali G; Pitchaiah KC; Arya RK; Kulabhi A
    Drug Deliv Transl Res; 2023 Apr; 13(4):946-965. PubMed ID: 36575354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Polymorph Form of Dexamethasone Acetate.
    Silva RPD; Ambrósio MFS; Piovesan LA; Freitas MCR; Aguiar DLM; Horta BAC; Epprecht EK; San Gil RADS; Visentin LDC
    J Pharm Sci; 2018 Feb; 107(2):672-681. PubMed ID: 29031975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supercritical CO
    Sadeghi F; Kamali H; Kouhestanian S; Hadizadeh F; Nokhodchi A; Afrasiabi Garekani H
    Pharm Dev Technol; 2022 Dec; 27(10):999-1008. PubMed ID: 36322612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of pH and method of crystallization on the solid physical form of indomethacin.
    Dubbini A; Censi R; Martena V; Hoti E; Ricciutelli M; Malaj L; Di Martino P
    Int J Pharm; 2014 Oct; 473(1-2):536-44. PubMed ID: 25064728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solution-state NMR spectroscopy of famotidine revisited: spectral assignment, protonation sites, and their structural consequences.
    Marosi A; Szalay Z; Béni S; Szakács Z; Gáti T; Rácz Á; Noszál B; Demeter Á
    Anal Bioanal Chem; 2012 Feb; 402(4):1653-66. PubMed ID: 22159514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precipitation of lysozyme nanoparticles from dimethyl sulfoxide using carbon dioxide as antisolvent.
    Muhrer G; Mazzotti M
    Biotechnol Prog; 2003; 19(2):549-56. PubMed ID: 12675600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Didanosine-loaded chitosan microspheres optimized by surface-response methodology: a modified "Maximum Likelihood Classification" approach formulation for reverse transcriptase inhibitors.
    Ferreira da Silva C; Severino P; Martins F; Santana MH; Souto EB
    Biomed Pharmacother; 2015 Mar; 70():46-52. PubMed ID: 25776478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theophylline formulation by supercritical antisolvents.
    Roy C; Vega-González A; Subra-Paternault P
    Int J Pharm; 2007 Oct; 343(1-2):79-89. PubMed ID: 17582714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissolution enhancement of Deflazacort using hollow crystals prepared by antisolvent crystallization process.
    Paulino AS; Rauber G; Campos CE; Maurício MH; de Avillez RR; Capobianco G; Cardoso SG; Cuffini SL
    Eur J Pharm Sci; 2013 May; 49(2):294-301. PubMed ID: 23557843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissolution properties, solid-state transformation and polymorphic crystallization: progesterone case study.
    Araya-Sibaja AM; Paulino AS; Rauber GS; Campos CE; Cardoso SG; Monti GA; Heredia V; Bianco I; Beltrano D; Cuffini SL
    Pharm Dev Technol; 2014 Nov; 19(7):779-88. PubMed ID: 24032356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation of indomethacin-saccharin cocrystals using supercritical fluid technology.
    Padrela L; Rodrigues MA; Velaga SP; Matos HA; de Azevedo EG
    Eur J Pharm Sci; 2009 Aug; 38(1):9-17. PubMed ID: 19477273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.